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Abstract Iberiotoxin (IbTX) is a remarkably selective K-K
toxin peptide (K-KTx) inhibitor of the maxi-K channel. In con-
trast, the highly homologous charybdotoxin inhibits both the
maxi-K and KV1.3 channels with similar high a⁄nity. The
present study investigates the molecular basis for this speci¢city
through mutagenesis of IbTX. The interactions of mutated pep-
tides with maxi-K and KV1.3 channels were monitored through
dose-dependent displacement of speci¢cally bound iodinated
K-KTx peptides from membranes expressing these channels.
Results of these studies suggest that the presence of a glycine
at position 30 in IbTX is a major determinant of its speci¢city
while the presence of four unique acidic residues in IbTX is
not. + 2002 Published by Elsevier Science B.V. on behalf of
the Federation of European Biochemical Societies.
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1. Introduction
Large-conductance calcium-activated (maxi-K) potassium
channels represent a unique class of potassium channels that
are synergistically activated by depolarizing membrane poten-
tials and intracellular calcium. Thus, the maxi-K channel pro-
vides an important link between calcium- and voltage-depen-
dent signaling processes. Because of these unique properties,
maxi-K channels play critical roles in a variety of physiolog-
ical processes. In smooth muscle, maxi-K channels regulate
uterine contractions [1], and they play a critical role in regu-
lating arterial tone and blood pressure [2,3]. Maxi-K channels
also regulate electrical tuning in cochlear hair cells [4], hor-
mone release in pituitary cells [5] as well as spike broadening
and neurotransmitter release in neurons [6]. Iberiotoxin
(IbTX), a highly selective K-K peptide (K-KTx) inhibitor of
the maxi-K channel [7], has proved invaluable in elucidating
the diverse physiological roles of these channels.
The K-KTx peptides inhibit the £ow of Kþ ions through the
Kþ channel pore and are powerful tools for probing the struc-
ture and function of Kþ channels [8] as well as for under-
standing their physiological function. The di¡erent K-KTx
subfamilies, shown in Fig. 1, display an extraordinary ability
to distinguish between the large family of voltage-gated po-
tassium (KV) channels and the maxi-K channel. Peptides from
the K-KTx 2.x and 3.x subfamilies block KV channels with
high a⁄nity but not the maxi-K channel [8,9]. Conversely,
peptides from the K-KTx 1.x subfamily display high a⁄nity
interactions with the maxi-K channel. Most K-KTx 1.x pep-
tides, such as charybdotoxin (ChTX or K-KTx 1.1), also in-
hibit KV1 channels with high a⁄nity [10,11]. However, two of
these toxins, IbTX (K-KTx 1.3) and limbatus toxin (LbTX or
K-KTx 1.4) are highly selective for the maxi-K channel. De-
spite its widespread use as a selective maxi-K channel inhib-
itor, the molecular basis for IbTX speci¢city is poorly under-
stood. In this work we examine the interactions of IbTX and
noxiustoxin (NxTX or K-KTx 2.1) mutants with maxi-K and
KV1.3 channels to reveal that a single residue in IbTX, glycine
30, is a major determinant of its speci¢city for the maxi-K
channel.
2. Materials and methods
2.1. Peptide
The plasmids pG9IbTX and pG9NxTX, encoding T7 gene 9, six
histidines, a factor Xa cleavage site and either the IbTX gene [12] or
the NxTX gene [9], were used to generate toxin mutants using a two-
step polymerase chain reaction mutagenesis strategy as described [12].
The identity of all DNA constructs was veri¢ed using dideoxy se-
quencing [13]. The Escherichia coli strain BL21 (DE3), harboring
the pG9IbTX or pG9NxTX plasmids, was cultured and induced
with isopropyl 1-thio-L-galactopyranoside, and the T7 gene 9 toxin
fusion protein was puri¢ed by DEAE ion exchange chromatography
as described [12]. After folding, the fusion protein was cleaved from
the toxin with TPCK-treated trypsin and puri¢ed by FPLC ion ex-
change [9] and by reverse phase high performance liquid chromatog-
raphy (HPLC) as described [12]. The identity of each peptide was
con¢rmed by either MALDI-MS mass spectrometric analysis or by
N-terminal sequencing of the ¢rst six amino acids (Commonwealth
Biotechnologies). Cyclization of the N-terminal glutamine in IbTX
mutants, performed as described [12], was veri¢ed either by MAL-
DI-MS mass spectrometric analysis or N-terminal sequencing of the
¢rst six amino acids before and after cyclization. The predicted and
measured masses for each peptide were IbTX-S10A (4232, 4231),
IbTX-S10A-D4N-D6N (4230, 4229.2), IbTX-S10A-D24N (4231,
4229.2), IbTX-S10A-D4N-D6N-D19N-D24N (4211, 4211), IbTX-
S10A-G30N (4289, 4287), NxTX-vThr1-vAsn39 (3980.7, 3978.4),
NxTX-N31G-vThr1-vAsn39 (3923.7, 3924.8). Puri¢cation and char-
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acterization of recombinant NxTX and NxTX-S14W were as de-
scribed [9]. The peptides were s 99% pure as judged by HPLC elution
pro¢les and mass spectrometric analysis. ChTX and IbTX were from
Peninsula Laboratories.
2.2. Transfection of TsA-201 cells and membranes
Maxi-K channels were transiently transfected into a TsA201 cell
line using the human K clone huR2(+) subcloned into a pCI-neo
vector and membrane preparation were as described [14]. Membranes
from HEK-293 cells stably transfected with the KV1.3 channel were
prepared as described [15].
2.3. Binding assays
The interaction of mutant peptides with the KV1.3 channel was
monitored by dose-dependent displacement of mono-iodinated hon-
gotoxin-1-A19Y/Y37F ([125I]HgTX-1-A19Y/Y37F) speci¢cally bound
to HEK membranes expressing KV1.3 channels as described [16].
Membranes were incubated with [125I]HgTX-1-A19Y/Y37F (2200
Ci/mmol) in the absence or presence of unlabeled mutant peptide until
equilibrium was achieved [16]. Non-speci¢c binding, determined from
the amount of radioactivity remaining after incubation with excess
unlabeled with NxTX-S14W [16], represented 6 10% of total binding.
At the end of the incubation period, samples were diluted with ice-
cold bu¡er and rapidly ¢ltered through Whatman GF/C ¢lters pre-
soaked with 0.5% polyethyleneimine and washed with ice-cold me-
dium as described [17]. Assays were performed in triplicate for each
experimental condition.
The interaction of peptides with maxi-K channels was monitored
from the dose-dependent displacement of the mono-iodinated IbTX-
D19Y/Y36F ([125I]IbTX-D19Y/Y36F) speci¢cally bound to mem-
branes expressing maxi-K channel alpha subunits as described [18].
Membranes were incubated with [125I]IbTX-D19Y/Y36F (2200 Ci/
mmol) in the absence or presence of unlabeled peptide until equilib-
rium was achieved as described [18]. Non-speci¢c binding, determined
from excess unlabeled IbTX, represented 6 15% of total binding.
Assays were performed in triplicate for each experimental condition.
Data were computer-¢tted to the general dose-response equation,
and then analyzed for toxin inhibition constant (Ki) values using the
method described [19]. Measurements were made a minimum of three
times and errors are described as standard errors of the mean.
3. Results and discussion
IbTX and ChTX display a remarkable di¡erence in their
speci¢city for maxi-K versus KV1.3 channels and yet their
three-dimensional solution 1H NMR structures [20,21] reveal
nearly super imposable alpha carbon backbone structures, see
Fig. 2. Thus, IbTX speci¢city is likely de¢ned by speci¢c
amino acids. Comparison of IbTX and ChTX reveals di¡er-
ences in sequence identity are localized to ¢ve structurally
discrete domains, I through V, Figs. 1 and 2. Domains I,
III, IV and V contribute to the peptide:channel binding sur-
face [22,23] and thus are likely to in£uence speci¢city.
ChTX and IbTX exhibit a striking di¡erence in electrostatic
structure [8] that is derived in part from four extra acidic
residues in IbTX (D4, D6, D19 and D24) that reside in do-
mains I, II and III, Fig. 1. To test whether these Asp residues
prevent a high a⁄nity interaction we generated four IbTX-
S10A mutants (D4N, D4N-D6N, D24N, D4N-D6N-D19N-
D24N) and examined their interactions with KV1.3 channels,
see Fig. 3 and Table 1. The S10A mutation, in both ChTX
[23] and IbTX [24], displays a V10-fold weaker interaction
that is manifested as a faster dissociation rate constant. The
faster dissociation kinetics seen with the S10A mutation will
facilitate future mechanistic characterization of mutant toxin
block of single maxi-K channels. This S10A mutation in
ChTX also causes a 10-fold weaker interaction with the Shak-
er KV channel [22] and thus does not in£uence speci¢city.
Fig. 1. Amino acid sequences for the K-KTx. Domains I, II, III, IV and V that de¢ne sequence di¡erences between ChTX and IbTX are indi-
cated. Residues in IbTX unique from ChTX are in bold. Acidic residues are shaded. Secondary structures, position of the beta turn and strictly
conserved cysteines are annotated. (See also Refs. [7,16,28^39].)
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HgTX-1 is a highly selective, high a⁄nity blocker of KV1.3
channels [16]. Thus, competition experiments with
[125I]HgTX-1-A19Y/Y37F provide a reliable means for mon-
itoring the interaction of mutant peptides with KV1.3 chan-
nels. Fig. 3 shows that ChTX displaces bound [125I]HgTX-1-
A19Y/Y37F from membranes containing KV1.3 channels with
an IC50 value of 140 pM. In contrast, IbTX-S10A (100 nM)
and the four charge mutants (300 to 1,000 nM) had no e¡ect
on bound [125I]HgTX-1-A19Y/Y37F, Fig. 3 and Table 1. Con-
versely, ChTX, IbTX-S10A and the same IbTX-S10A charge
mutants displace [125I]IbTX-D19Y/Y36F from membranes ex-
pressing maxi-K channels with Ki values ranging from 7 to
150 pM, Fig. 4 and Table 1. The results of these binding
measurements suggest that charge alone cannot explain the
remarkable speci¢city of IbTX for the maxi-K vs. KV chan-
nels.
Among the ¢ve structural domains that distinguish IbTX
and ChTX, the single glycine in domain IV of IbTX is unique,
in that all K-KTx peptides known to block KV channels con-
tain an asparagine at this position, Fig. 1. To test the role of
this Gly in IbTX speci¢city we generated the IbTX-S10A mu-
tant, G30N, and examined its interaction with the KV1.3
channel, Fig. 3 and Table 1. Binding of [125I]HgTX-1-A19Y/
Y37F was inhibited by IbTX-S10A-G30N with a Ki value of
43 nM. Thus, the G30N mutation in IbTX promotes a high
a⁄nity interaction with the KV1.3 channel. In contrast, the
IbTX-S10A-G30N (Ki 370 pM) mutation weakens binding to
the maxi-K channel by about three-fold compared to IbTX-
S10A (Ki 130 pM), Fig. 4 and Table 1. These data taken
together strongly suggest that the nature of residue 30, in
the peptide beta turn, is a major determinant of speci¢city.
To test whether ‘Asn 30’ in the beta turn is generally im-
portant for the interaction of K-KTx peptides with KV chan-
nels we mutated this analogous ‘Asn31’ in NxTX (K-KTx 2.1).
NxTX blocks with high a⁄nity KV1.3 but not maxi-K chan-
nels [9]. Some of the NxTX speci¢city for KV1.3 results from
the increased backbone length at the N- and C-termini [9,25].
The NxTX deletion mutant, NxTX-vThr1-vAsn39, truncated
by one residue each at the N- and C-termini has the
same backbone length as IbTX and ChTX. Fig. 5 shows
that NxTX and NxTX-vThr1-vAsn39 displace bound
[125I]HgTX-1-A19Y/Y37F from membranes containing
KV1.3 channels with IC50 values of 0.6 and 8 nM, respec-
tively. In contrast, the N31G mutant of NxTX-vThr1-
vAsn39 has no e¡ect on bound [125I]HgTX-1-A19Y/Y37F at
300 nM. This ¢nding is also consistent with previous studies
where mutation of this ‘Asn 30’ in ChTX and agitoxin-2
(AgTX-2 or K-KTx 3.2) weakened binding to the Shaker
KV channel by 840- [22] and 700-fold [26], respectively, com-
pared to the wild-type peptides. Together these ¢ndings sug-
gest that ‘Asn 30’ in the K-KTx beta turn is critical for its high
a⁄nity interaction with KV channels.
Our ¢nding that replacing the smaller Gly in IbTX with the
larger Asn restores a high a⁄nity interaction with KV chan-
nels is remarkable, and it suggests that steric interactions are
not responsible for the e¡ects. The most reasonable interpre-
tation of this result is that Asn 30 forms a critical hydrogen
bond with a H-bond acceptor on the KV channel and that a
similar H-bond is not critical for interaction of K-KTx pep-
tides with the maxi-K channel. Indeed, recent models of
ChTX bound to the KV1.3 outer vestibule reveal the presence
of an important H-bond between Asn30 in ChTX and Asp
Fig. 2. Sequence di¡erences between IbTX and ChTX are de¢ned
by ¢ve structurally discrete domains. Superimposed K-carbon back-
bone structures for IbTX [21] are in green, and for ChTX [20] in
blue.
Fig. 3. E¡ects of ChTX and mutants of IbTX-S10A on [125I]HgTX-
1-A19Y/Y37F binding to KV1.3 channels. Speci¢c binding of
[125I]HgTX-1-A19Y/Y37F to HEK membranes transfected with
KV1.3 channels is plotted as a function of increasing concentrations
of ChTX (¢lled circles), IbTX-S10A (¢lled triangles), IbTX-S10A-
G30N (open squares) and IbTX-S10A-D4N-D6N-D19N-D24N
(¢lled squares). Membranes were incubated in a medium containing
0.2 pM [125I]HgTX-1-A19Y/Y37F, 100 mM NaCl, 5 mM KCl, 20
mM Tris^HCl pH 7.4, 0.1% bovine serum albumin and di¡erent
concentrations of unlabeled peptide. Incubations were performed at
room temperature for ca 20 h. Non-speci¢c binding was determined
in the presence of 100 nM NxTX-S14W.
Table 1
E¡ects of ChTX, IbTX-S10A and mutants on binding to maxi-K and KV1.3 channels
Peptide Ki (nM) maxi-K Ki (nM) KV1.3
ChTX 0.007T0.002 0.034T 0.006
IbTX-S10A 0.13T 0.02 no e¡ect 100 nM
IbTX-S10A-D4N 0.02T 0.0002 no e¡ect 1,000 nM
IbTX-S10A-D4N-D6N 0.007T0.0008 no e¡ect 300 nM
IbTX-S10A-D24N 0.15T 0.037 no e¡ect 300 nM
IbTX-S10A-D4N-D6N-D19N-D24N 0.027T0.006 no e¡ect 300 nM
IbTX-S10A-G30N 0.37T 0.1 43T 25
Ki values were determined from competition experiments with either [125I]HgTX-1-A19Y/Y37F binding to KV1.3 channels or [125I]IbTX-D19Y/
Y36F binding to maxi-K channels as described in Figs. 3 and 4, respectively.
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381 in the channel [27]. For the maxi-K channel model, the
analogous H-bond between Asn30 in the peptide and Glu276
in the channel cannot be formed [27]. Together, these results
suggest that IbTX speci¢city for the maxi-K vs. KV1.3 chan-
nel results, in part, from the absence of a critical H-bond
between Asp381 in the channel and Gly 30 in IbTX.
Our ¢ndings clearly show that Asn 30 in the K-KTx pep-
tides is critical for their interaction with KV channels. How-
ever, the interaction of IbTX-S10A-G30N with the KV1.3
channel is still V1000-fold weaker compared to ChTX. Since
the S10A mutation weakens binding to KV channels by no
more than 10-fold [22], it is likely that other residues in do-
mains I, III and V of IbTX contribute to its speci¢city. Stud-
ies with synthetic ChTX-IbTX chimera also suggest that the
major determinants for IbTX speci¢city lie in the C-terminal
half of IbTX [10]. Approaches to understand the molecular
basis for K-KTx speci¢city are likely to reveal novel features
of the maxi-K and KV1.3 outer vestibules. Moreover, the
critical role of Asn30 in de¢ning K-KTx speci¢city will be
instrumental in the rational design of speci¢c K-KTx blockers
and potassium channel inhibitors.
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